| Michael E Watts, MD | |
|
1840 Amherst St, Winchester, VA 22601-2808 | |
| (540) 536-8000 | |
| (540) 536-7681 |
| Full Name | Michael E Watts |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 1840 Amherst St, Winchester, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457310302 | NPI | - | NPPES |
| 010029066 | Medicaid | VA | |
| 1809821000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 0101229828 (Virginia) | Primary |
| Entity Name | Winchester Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679711261 PECOS PAC ID: 0244134021 Enrollment ID: O20031124000061 |
News Archive
The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, announced today that it has acquired Hurricane Health and Rehabilitation Center, a 48-bed skilled nursing facility in Hurricane, Utah.
ALLOZYNE Inc. announced today the signing of a worldwide, co-exclusive licensing agreement with Sigma-Aldrich giving ALLOZYNE a license for the use of cycloaddition chemistry in the development of therapeutics and diagnostics. Sigma-Aldrich currently holds broad, worldwide intellectual property for the use of cycloaddition chemistry to conjugate biomolecules.
Scientists from the Garvan Institute of Medical Research in Sydney, Australia, are suggesting a new approach to determining the risk of fracture in individuals with the brittle bone disease, osteoporosis, which could have treatment implications.
The $40 million expansion of The Cardiac Centers of Mercy & Unity Hospitals reaches a significant milestone this week with the opening of the most technologically advanced cardiovascular catheterization laboratories in Minnesota.
Optivia Biotechnology Inc., a leading provider of in vitro transporter assay services, today announced the launch of the OptiDDITM Suite, a novel assay panel that assesses the most clinically significant transporter-related drug-drug interactions (DDIs), as identified by the International Transporter Consortium (ITC) in its report "Membrane Transporters in Drug Development" (Nature Reviews-Drug Discovery, March 2010).
› Verified 6 days ago
| Entity Name | Winchester Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487907341 PECOS PAC ID: 7214181585 Enrollment ID: O20130214000243 |
News Archive
The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, announced today that it has acquired Hurricane Health and Rehabilitation Center, a 48-bed skilled nursing facility in Hurricane, Utah.
ALLOZYNE Inc. announced today the signing of a worldwide, co-exclusive licensing agreement with Sigma-Aldrich giving ALLOZYNE a license for the use of cycloaddition chemistry in the development of therapeutics and diagnostics. Sigma-Aldrich currently holds broad, worldwide intellectual property for the use of cycloaddition chemistry to conjugate biomolecules.
Scientists from the Garvan Institute of Medical Research in Sydney, Australia, are suggesting a new approach to determining the risk of fracture in individuals with the brittle bone disease, osteoporosis, which could have treatment implications.
The $40 million expansion of The Cardiac Centers of Mercy & Unity Hospitals reaches a significant milestone this week with the opening of the most technologically advanced cardiovascular catheterization laboratories in Minnesota.
Optivia Biotechnology Inc., a leading provider of in vitro transporter assay services, today announced the launch of the OptiDDITM Suite, a novel assay panel that assesses the most clinically significant transporter-related drug-drug interactions (DDIs), as identified by the International Transporter Consortium (ITC) in its report "Membrane Transporters in Drug Development" (Nature Reviews-Drug Discovery, March 2010).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael E Watts, MD 1840 Amherst St, Winchester, VA 22601-2808 Ph: (540) 536-8000 | Michael E Watts, MD 1840 Amherst St, Winchester, VA 22601-2808 Ph: (540) 536-8000 |
News Archive
The Ensign Group, Inc., the parent company of the Ensign group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, announced today that it has acquired Hurricane Health and Rehabilitation Center, a 48-bed skilled nursing facility in Hurricane, Utah.
ALLOZYNE Inc. announced today the signing of a worldwide, co-exclusive licensing agreement with Sigma-Aldrich giving ALLOZYNE a license for the use of cycloaddition chemistry in the development of therapeutics and diagnostics. Sigma-Aldrich currently holds broad, worldwide intellectual property for the use of cycloaddition chemistry to conjugate biomolecules.
Scientists from the Garvan Institute of Medical Research in Sydney, Australia, are suggesting a new approach to determining the risk of fracture in individuals with the brittle bone disease, osteoporosis, which could have treatment implications.
The $40 million expansion of The Cardiac Centers of Mercy & Unity Hospitals reaches a significant milestone this week with the opening of the most technologically advanced cardiovascular catheterization laboratories in Minnesota.
Optivia Biotechnology Inc., a leading provider of in vitro transporter assay services, today announced the launch of the OptiDDITM Suite, a novel assay panel that assesses the most clinically significant transporter-related drug-drug interactions (DDIs), as identified by the International Transporter Consortium (ITC) in its report "Membrane Transporters in Drug Development" (Nature Reviews-Drug Discovery, March 2010).
› Verified 6 days ago
Jillian H Call, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8000 Fax: 540-536-7681 | |
Michael Mayer Romain Khafi, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8000 Fax: 540-536-7780 | |
Michael J Mcauliffe, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8000 Fax: 540-536-7681 | |
Dr. Alexis Mccabe, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-5100 Fax: 540-536-0235 | |
Steven James Bauer, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 254-220-9778 | |
Chad B Dunn, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8708 | |
Scott K King, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1840 Amherst St, Winchester, VA 22601 Phone: 540-536-8708 |